Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 7, 2009; 15(37): 4653-4658
Published online Oct 7, 2009. doi: 10.3748/wjg.15.4653
Published online Oct 7, 2009. doi: 10.3748/wjg.15.4653
Treatment of variceal bleeding |
Pharmacological therapy |
Somatostatin: initial bolus (24-48 h) and a perfusion (5 d) |
Octreotide: initial bolus (24-48 h) and a perfusion (5 d) |
Terlipressin: important side effects |
Primary prophylaxis |
β-blockers non-selective: propranolol, nadolol |
Isosorbide 5-mononitrate |
Secondary prophylaxis |
β-blockers non-selective: propranolol, nadolol |
Isosorbide 5-mononitrate |
Endoscopy therapy: band ligation, sclerotherapy |
Cause of low hematocrit | Possible contributing factors |
Hemorrhage and/or iron deficiency | Alcoholic gastritis |
Portal hypertension | |
Peptic ulceration | |
Hemolysis | Chronic liver disease and/or cirrhosis |
Zieve syndrome | |
Spur cell anemia of severe liver disease | |
Reduced erythropoiesis | Anemia of chronic disease |
Nutritional (e.g. folic acid deficiency) | |
Sideroblastic anemia | |
Alcohol toxicity | |
Hypersplenism | Portal hypertension |
Hemodilution | Fluid retention of chronic liver disease |
Aggressive intravenous fluid therapy |
- Citation: Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol 2009; 15(37): 4653-4658
- URL: https://www.wjgnet.com/1007-9327/full/v15/i37/4653.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4653